Generation of pralatrexate resistant T‐cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L Scotto, C Kinahan, B Casadei… - Genes …, 2020 - Wiley Online Library
While pralatrexate (PDX) has been successfully developed for the treatment of T‐cell
lymphoma, the mechanistic basis for its T‐cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T‐cell selectivity and acquired resistance remains …
[PDF][PDF] Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L Scotto, C Kinahan, B Casadei, M Mangone… - 2020 - scholar.archive.org
While pralatrexate (PDX) has been successfully developed for the treatment of T-cell
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L Scotto, C Kinahan, B Casadei, M Mangone… - GENES …, 2020 - cris.unibo.it
While pralatrexate (PDX) has been successfully developed for the treatment of T-cell
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
[引用][C] Generation of pralatrexate resistant T‐cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L Scotto, C Kinahan, B Casadei, M Mangone… - Genes, Chromosomes …, 2020 - cir.nii.ac.jp
Generation of pralatrexate resistant T‐cell lymphoma lines reveals two patterns of acquired
drug resistance that is overcome with epigenetic modifiers | CiNii Research CiNii 国立情報学 …
drug resistance that is overcome with epigenetic modifiers | CiNii Research CiNii 国立情報学 …
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers.
L Scotto, C Kinahan, B Casadei… - Genes …, 2020 - europepmc.org
While pralatrexate (PDX) has been successfully developed for the treatment of T‐cell
lymphoma, the mechanistic basis for its T‐cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T‐cell selectivity and acquired resistance remains …
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L Scotto, C Kinahan, B Casadei, M Mangone… - 2020 - academiccommons.columbia.edu
While pralatrexate (PDX) has been successfully developed for the treatment of T-cell
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L Scotto, C Kinahan, B Casadei… - Genes …, 2020 - pubmed.ncbi.nlm.nih.gov
While pralatrexate (PDX) has been successfully developed for the treatment of T-cell
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
[HTML][HTML] Generation of pralatrexate resistant T‐cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L Scotto, C Kinahan, B Casadei… - Genes …, 2020 - ncbi.nlm.nih.gov
While pralatrexate (PDX) has been successfully developed for the treatment of T‐cell
lymphoma, the mechanistic basis for its T‐cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T‐cell selectivity and acquired resistance remains …
[PDF][PDF] Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L Scotto, C Kinahan, B Casadei, M Mangone… - 2020 - academia.edu
While pralatrexate (PDX) has been successfully developed for the treatment of T-cell
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T-cell selectivity and acquired resistance remains …
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers.
L Scotto, C Kinahan, B Casadei… - Genes …, 2020 - europepmc.org
While pralatrexate (PDX) has been successfully developed for the treatment of T‐cell
lymphoma, the mechanistic basis for its T‐cell selectivity and acquired resistance remains …
lymphoma, the mechanistic basis for its T‐cell selectivity and acquired resistance remains …